Omega-3 reduces breast cancer risk in obese women

According to a study by Professor Andrea Manni and colleagues, omega-3 fatty acid supplementation can help reduce the risk of breast cancer in postmenopausal obese women.

A study by Professor Andrea Manni at the Pennsylvania Academy of Medicine (USA) and colleagues recently published in the journal Cancer Prevention Research shows that omega-3 fatty acid supplementation can help reduce the risk of breast cancer in postmenopausal obese women.

The research team tested 266 postmenopausal women with high breast density who were of normal weight, overweight, and obese. The study aimed to measure changes in breast density over two years.

Research suggests that omega-3 fatty acids may reduce the risk of breast cancer in postmenopausal obese women.

Participants were divided into five different treatment groups: two groups taking the antiestrogen drug Raloxifene at doses of 60 mg/day and 30 mg/day, one group taking the omega-3 drug Lovaza at 4 mg/day, one group taking 30 mg of Raloxifene combined with 4 mg of Lovaza, and a control group that received no treatment.

After two years, the team found a link between blood levels of omega-3 fatty acids and reduced breast density, but only in obese women.

According to the National Cancer Institute, women with high breast density are four to six times more likely to develop breast cancer than women with low breast density.

“Omega-3 fatty acids have anti-inflammatory effects, and that’s one of the reasons we suspected they might be particularly effective in obese women,” Dr. Manni explains.

According to VOV